Medication info
Phenacet Tablets (Tramadol Hydrochloride, Acetaminophen)

Phenacet Tablets (Tramadol Hydrochloride, Acetaminophen)

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›325mg / 1 tabletTramadol Hydrochloride›37.5mg / 1 tablet
Manufacturer / importer
Medica Korea Co., Ltd.
Appearance
Pale yellow, oval film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200805275 · Notified 2008.05.08 · Insurance code 646002790

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Elderly Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to patients aged 75 years or older, administer this medication at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, this medication does not need to be readministered after dialysis to maintain its analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval for patients with moderate hepatic impairment. Do not administer this medication to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, without exceeding 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term use is required due to the nature and severity of the condition, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Ingredients

Manufacturer
Medica Korea Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute and chronic pain
View approved original text

This medication is used to effectively relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Elderly Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when administered orally to patients aged 75 years or older, administer this medication at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance less than 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, this medication does not need to be readministered after dialysis to maintain its analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval for patients with moderate hepatic impairment. Do not administer this medication to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older: The dose should be adjusted according to the patient's pain severity and response to treatment. An initial dose of 2 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, without exceeding 8 tablets per day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term use is required due to the nature and severity of the condition, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Precautions

This medication may impose stress on the liver, so those who regularly consume more than three drinks a day should consult a doctor or pharmacist before use. The acetaminophen component may rarely cause serious skin reactions, so if a rash or hypersensitivity occurs after taking the medication, discontinue use immediately and consult medical professionals. The tramadol component may increase the risk of seizures if the recommended dose is exceeded, and the risk may further increase if taken with certain antidepressants or opioid analgesics. Patients with compromised respiratory function, especially those with acute or severe bronchial asthma, may experience serious respiratory depression while taking this medication and should use it in a monitored medical environment. Taking this medication with alcohol or central nervous system depressants such as benzodiazepines may result in severe drowsiness, respiratory depression, or coma, so co-administration should be avoided or approached with caution. Patients with head injuries or brain diseases should be cautious when taking this medication as it may exacerbate increased intracranial pressure or respiratory depression. The tramadol component may induce psychological or physical dependence, so dependency should be carefully monitored during long-term use. Patients with impaired liver function may risk liver damage due to the acetaminophen component and should consult a doctor before use. Especially for those who are ultra-rapid metabolizers of CYP2D6, there is a risk of excessive production of the active metabolite leading to severe respiratory depression, so caution is required. This medication should not be administered to children, particularly those under 12 years old or adolescents under 18 who have undergone tonsillectomy or adenoidectomy, and it is advisable to avoid use in those aged 12 to 18 with risk factors. This medication may induce sleep apnea or hypoxia, so continuous observation for worsening symptoms is necessary. There may be a risk of hyponatremia, so especially elderly patients or those at risk for hyponatremia should closely monitor symptoms while using it. This medication may interact with multiple drugs, so if other medications are being taken, it is essential to inform healthcare providers. Women who are pregnant or may become pregnant should consult a doctor before taking this medication, and it is advisable to avoid it while breastfeeding. Drowsiness or dizziness may occur during use, so caution is needed when driving or operating machinery. In case of overdose, severe respiratory depression or liver damage may occur, so strict adherence to dosing is necessary, and immediate medical attention should be sought in case of overdose. This medication should be stored in a safe place out of the reach of children, and care should be taken to prevent misuse and accidental ingestion.

Side effects

Liver damage, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, death, hyponatremia, decreased appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, nervousness, emotional instability, euphoria, reduced libido, sleep disorders, confusion, disorientation, agitation, abnormal dreams, substance abuse, hallucinations, withdrawal syndrome, migraines, hypersomnia, sensory impairment, tremors, sensory abnormalities, attention deficit, fainting, memory impairment, psychomotor agitation, sedation, amnesia, perceptual abnormalities, convulsions, blurred vision, visual impairment, miosis, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, increased liver enzymes, generalized pruritus, cold sweat, urinary disorders, erectile dysfunction, fatigue, chest pain, emotional abnormality, chills, chest discomfort, lethargy, drug withdrawal syndrome, thirst, irritability, warmth, weight loss, increased serum creatinine, anaphylactic reaction, unstable emotions, delirium, suicidal thoughts, muscle rigidity, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disorders, prolonged prothrombin time, fixed rash, fatigue, fever, edema, rigidity, fainting, congestive heart failure, vertigo, confusion, migraine exacerbation, involuntary muscle contractions, dyspnea, coughing, bronchitis, urinary retention, frequency of urination, abnormal kidney function tests, oliguria, increased sweating, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, insomnia, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, decreased platelets, arrhythmia, exacerbation of hypertension, aortic stenosis, hemorrhage, increased cholesterol, tinnitus, hip pain, thigh pain, allergic rhinitis, nasal bleeding, abnormal vision, progression of bile duct cancer, foreign body sensation in the eye, progression of liver cancer, abnormal liver function, nausea, dizziness, dyspnea, confusion, migraine, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, vomiting, dyspepsia, confusion, multiple organ failure, anaphylaxis, intentional overdose, chest discomfort, withdrawal symptoms, anxiety, sweating, rigidity, pain, diarrhea, upper respiratory syndrome, hiccup, agitation, nervousness, hyperactivity, gastrointestinal symptoms, urticaria, bronchospasm, toxic skin necrosis, allergic reactions, severe anxiety, hallucinations, perceptual abnormalities, tinnitus, abnormal central nervous system response, QT prolongation, liver failure, renal tubular necrosis, hypoglycemia, coagulopathy, respiratory depression, hypersomnia, coma, cardiac arrest, death, fever, edema, rigidity, fainting

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be kept in an airtight container and stored at room temperature between 1°C and 30°C. Proper storage will help maintain the medication's effectiveness over time.

Appearance and packaging

Appearance

Pale yellow, oval film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.